Drug recall alerts and consumer safety news updated hourly http://www.recallowl.com/Drug+and+Medical+Recalls/Drugs Thu, 27 Feb 2014 14:08:21 +0100 http://www.recallowl.com/images/rss.gif http://www.recallowl.com The feed is managed/created by RecallOwl.com (http://www.recallowl.com). http://www.recallowl.com/Drug+and+Medical+Recalls/Drugs/Agila+Specialties+Private+Limited+Initiates+Voluntary+Nationwide+Recall+of+10+Lots+of+Etomidate+Injection+2+mg%2FmL+-+10+mL+and+20+mL+due+to+the+Presence+of+Particulate+Matter+and%2For+Illegible+and+Missing+Lot+Number+and%2For+Expiry+Date ... Wed, 19 Feb 2014 07:00:00 +0100 http://www.recallowl.com/Drug+and+Medical+Recalls/Drugs/Ben+Venue+Laboratories%2C+Inc.+Issues+A+Voluntary+Nationwide+Patient+Level+Recall+Of+Acetylcysteine+Solution+10%25%2C+Usp%2C+Lot+2005479 - February 14, 2014 - Ben Venue Laboratories, Inc. today issued a nationwide voluntary product recall: Acetylcysteine Solution 10%, USP, (Manufactured for Roxane Laboratories, Inc.) 10%, 30 mL per vial - NDC #0054-3025-02 - Lot 2005479 - Exp. Date March 2014 This voluntary recall was initiated on February 14, 2014 after the discovery of a single visible glass particle in a vial within the lot listed above. There ... Fri, 14 Feb 2014 07:00:00 +0100 http://www.recallowl.com/Drug+and+Medical+Recalls/Drugs/Tandem+Diabetes+Care+Expands+Voluntary+Recall+for+Select+Lots+of+Insulin+Cartridges+Used+with+t%3Aslim+Insulin+Pump - January 20, 2014 - San Diego - Tandem Diabetes CareŽ, Inc. (NASDAQ: TNDM), or Tandem, today announced that it is expanding a voluntary recall of specific lots of insulin cartridges that are used with the t:slimŽ Insulin Pump. The affected cartridges may be at risk for leaking. This could potentially result in the device delivering too much or too little insulin, which can lead to a serious adverse event.... Wed, 12 Feb 2014 07:00:00 +0100 http://www.recallowl.com/Drug+and+Medical+Recalls/Drugs/Stemvida+International+Corporation+Recalls+StemAlive+90+Capsules+Containing+Undeclared+Milk - January 17, 2014 - Stemvida International Corporation of Ontario California is recalling StemAlive 90 Capsules, because it contains undeclared milk. People who have an allergy or severe sensitivity to milk (bovine colostrum) run the risk of serious or life-threatening allergic reaction if they consume this product. The product is in a white plastic bottle with white lid, the brand is StemVida International with a white and gold label. The... Fri, 17 Jan 2014 07:00:00 +0100 http://www.recallowl.com/Drug+and+Medical+Recalls/Drugs/Human+Science+Foundation+Issues+Voluntary+Nationwide+Recall+of+Pro+ArthMax+Due+to+Undeclared+Active+Pharmaceutical+Ingredients - Jan 13, 2014 - Gardena, CA, Human Science Foundation is voluntarily recalling all lots of Pro ArthMax 120 count bottle, labeled and sold as a dietary supplement to the consumer level. The product has been found to contain undeclared active pharmaceutical ingredients (APIs), making it an unapproved new drug. FDA sample analysis tested the product to contain the following APIs: 2.4mg of Chlorzoxazone, 0.78mg of Nefopam, 2.5mg of Diclofenac, 7.7mg... Tue, 14 Jan 2014 07:00:00 +0100 http://www.recallowl.com/Drug+and+Medical+Recalls/Drugs/Tandem+Diabetes+Care+Initiates+Voluntary+Recall+for+Specific+Lots+of+Insulin+Cartridges+Used+with+t%3Aslim+Insulin+Pump - SAN DIEGO - January 10, 2014 - Tandem Diabetes CareŽ, Inc. (NASDAQ: TNDM) today announced that it is initiating a voluntary recall of specific lots of insulin cartridges that are used with the t:slimŽ Insulin Pump. The affected cartridges may be at risk for leaking. The cause of the recall was identified during Tandem's internal product testing, and has not been associated with any complaints or adverse events reported by custo... Tue, 14 Jan 2014 07:00:00 +0100 http://www.recallowl.com/Drug+and+Medical+Recalls/Drugs/Baxter+Initiates+Nationwide++Voluntary+recall+Of+Select+Lots+of+Premix+Parenteral+Nutrition - January 3, 2014 - Baxter International Inc. announced today it has initiated a voluntary recall in the United States of two lots of CLINIMIX and one lot of CLINIMIX E Injection parenteral nutrition products to the user level due to complaints of particulate matter found in the products. If infused, particulate matter may result in blockages of blood vessels, which can result in stroke, heart attack, or damage to other organs such as the kidney ... Fri, 03 Jan 2014 07:00:00 +0100 http://www.recallowl.com/Drug+and+Medical+Recalls/Drugs/Baxter+Initiates+Worldwide+Voluntary+Recall+Of+Select+Lots+Of+5+percent+Dextrose+Injection%2C+USP+And+0.9+percent+Sodium+Chloride+Injection%2C+USP+Intravenous+%28IV%29+Solutions - December 23, 2013 - Baxter International Inc. announced today it has initiated a voluntary recall to the hospital/user level of one lot of 5% Dextrose Injection, USP and four lots of 0.9% Sodium Chloride Injection, USP due to particulate matter found in the solutions. Injecting a product containing particulate matter may result in blockages of blood vessels, which can result in stroke, heart attack or damage to other organs such as the ki... Thu, 26 Dec 2013 07:00:00 +0100 http://www.recallowl.com/Drug+and+Medical+Recalls/Drugs/Hospira+Issues+a+Voluntary+Nationwide+Recall+of+One+Lot+of+Lidocaine+HCl+Injection%2C+USP%2C+2%25%2C+5+Ml+in+5+Ml+Vial%2C+Due+to+Presence+of+Particulate+Matter - December 23, 2013 - Hospira, Inc. (NYSE: HSP), announced today it will initiate a voluntary nationwide recall to the user level for one lot of Lidocaine HCl Injection, USP, 2%, 5 mL Single-Dose Vial (NDC 0409-2066-05), Lot 32-135-DD, expiration date 1AUG2015. The recall is due to a reddish orange particulate on the inner surface and floating in the solution. If particulate goes undetected and solution is administered, the particle may pot... Mon, 23 Dec 2013 07:00:00 +0100 http://www.recallowl.com/Drug+and+Medical+Recalls/Drugs/Alexion+Provides+Update+on+Previously+Communicated+November+2013+Voluntary+Nationwide+Recall+of+Two+Lots+of+Soliris+%28eculizumab%29+Concentrated+Solution+for+Intravenous+Infusion - December 13, 2013 - Cheshire, Conn., - Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) today is providing further information regarding a previously communicated voluntary recall of two lots of Soliris Ž (eculizumab) Concentrated Solution for Intravenous Infusion. As stated on Nov. 12, 2013, the two lots were found to contain visible particles. At that time, Alexion provided instructions to return any unused vials of Soliris from these two lots at... Fri, 13 Dec 2013 07:00:00 +0100 http://www.recallowl.com/Drug+and+Medical+Recalls/Drugs/Baxter+Initiates+Nationwide+Voluntary+Recall+of+One+Lot+of+Nitroglycerin+in+5%25+Dextrose+Injection - November 27, 2013 - Baxter International Inc. announced today it has initiated a voluntary recall of one lot of Nitroglycerin in 5% Dextrose Injection due to particulate matter found in one vial. If infused, particulate matter could lead to potential venous and/or arterial thromboembolism (blockage of blood vessels.) Other adverse events associated with injection of particulate matter include inflammation due to foreign material, particularly i... Wed, 27 Nov 2013 07:00:00 +0100 http://www.recallowl.com/Drug+and+Medical+Recalls/Drugs/Deseo+Rebajar+Inc.+Issues+Voluntary+Puerto+Rico+Recall+of+Adipotrim+XT+Due+to+Underclared+Fluoxetine ... Thu, 21 Nov 2013 07:00:00 +0100 http://www.recallowl.com/Drug+and+Medical+Recalls/Drugs/Perrigo+Initiates+Nationwide+Voluntary+Product+Recall+of+Acetaminophen+Infant+Suspension+Liquid%2C+160+mg%2F5+mL%2C+Due+to+a+Potential+Defect+with+the+Co-packaged+Oral+Syringe ... Fri, 01 Nov 2013 07:00:00 +0100 http://www.recallowl.com/Drug+and+Medical+Recalls/Drugs/Hospira+Issues+a+Voluntary+Nationwide+Recall+of+One+Lot+of+0.25%25+Marcaine%26%238482%3B+%28Bupivacaine+HCL+Injection%2C+USP%29%2C+75mg%2F30ml%2C+Single-Dose+-+Preservative+Free+Vial+Due+to+Presence+of+Particulate+Matter - LAKE FOREST, Ill., - Oct. 18, 2013 - Hospira, Inc. (NYSE: HSP), announced today it will initiate a voluntary nationwide recall to the user level for one lot of 0.25% Marcaine™ (Bupivacaine HCl Injection, USP), 75 mg/30 mL, Single-dose Vial - Preservative Free (NDC 0409-1559-30), Lot 25-220-DD. The recall is due to a confirmed customer report of discolored solution with visible particles inside the glass vial as well as em... Fri, 18 Oct 2013 07:00:00 +0100 http://www.recallowl.com/Drug+and+Medical+Recalls/Drugs/Nephron+Pharmaceuticals+Corporation+Announces+Voluntary+Recall+of+Albuterol+Sulfate+Inhalation+Solution%2C+0.083%25 - October 10, 2013 - Nephron Pharmaceuticals Corporation (NPC) has initiated a voluntary recall, at the retail level, as a precautionary measure, due to results from our internal monitoring processes. NPC is asking retailers to remove the affected lots from store shelves and is asking consumers to discontinue use and dispose of any product they may have that is included in this recall. This voluntary recall will affect the following product: ... Thu, 17 Oct 2013 07:00:00 +0100 http://www.recallowl.com/Drug+and+Medical+Recalls/Drugs/B.+Braun+Medical+Inc.+Issues+Voluntary+Nationwide+Recall+of+Lot+H3A744%2C+1+gram+Cefepime+for+Injection+USP+and+Dextrose+Injection+USP+Due+to+Visible+Particulate+Matter - October 15, 2013 - B. Braun Medical Inc. (B.Braun) is voluntarily recalling one lot of 1g Cefepime for Injection USP and Dextrose Injection USP (Lot H3A744, catalog 3193-11) to the consumer level. The 1g Cefepime for Injection USP and Dextrose Injection USP lot has been found to contain visible organic particulate matter in a reserve sample unit. B.Braun has not received any reports of adverse events related to this lot to date. Visible p... Tue, 15 Oct 2013 07:00:00 +0100 http://www.recallowl.com/Drug+and+Medical+Recalls/Drugs/H%26H+Medical+Corporation+Issues+Nationwide+Recall+of+Emergency+Cricothyrotomy+Kit - October 4, 2013 - On August 27, 2013, H&H Medical Corporation initiated a nationwide recall of 6,619 units of the H&H Emergency Cricothyrotomy Kit. The product has been found to show the potential for a defective cuff balloon on the provided endotracheal airway. Consumers who have product should stop using the product and return them to their original place of purchase for immediate credit. Distributors are instructed to return al... Fri, 04 Oct 2013 07:00:00 +0100 http://www.recallowl.com/Drug+and+Medical+Recalls/Drugs/Hospira+Issues+A+Voluntary+Nationwide+Recall+Of+One+Lot+Of+1%25+Lidocaine+HCL+Injection+Due+To+The+Presence+Of+Dark+Particulate - October 4, 2013 - LAKE FOREST, Ill., - Hospira, Inc. (NYSE: HSP), announced today it has initiated a voluntary nationwide recall of one lot of 1% Lidocaine HCI Injection, USP, 10 mg/mL, 20 mL Multiple-dose Fliptop Vial, NDC 0409-4276-01 Lot 25-090-DK (the lot number may be followed by 01 or 02). This action is due to one confirmed customer report of visible particulate, identified in the primary container, in the form of dark red/black particle... Fri, 04 Oct 2013 07:00:00 +0100 http://www.recallowl.com/Drug+and+Medical+Recalls/Drugs/HOSPIRA+ISSUES+A+VOLUNTARY+NATIONWIDE+RECALL+OF+ONE+LOT+OF+METOCLOPRAMIDE+INJECTION%2C+USP%2C+AND+TWO+LOTS+OF+ONDANSETRON+INJECTION%2C+USP%2C+DUE+TO+GLASS+%28GLASS+STRANDS%29+PARTICULATES+CAUSED+BY+GLASS+SUPPLIER+DEFECT - October 1, 2013 - Hospira, Inc. (NYSE: HSP), announced today it initiated a voluntary nationwide recall of one lot of Metoclopramide Injection, USP, 10 mg/2 mL (5 mg/mL), NDC 0409-3414-01, Lot 28-104-DK and two lots of Ondansetron Injection, USP, 4 mg/2 mL, (2 mg/mL), NDC 0409-4755-03, Lots 29-484-DK and 29-510-DK. This action is due to a confirmed vial defect where glass particulate matter (glass strands) were identified as being affixed to th... Wed, 02 Oct 2013 07:00:00 +0100 http://www.recallowl.com/Drug+and+Medical+Recalls/Drugs/Haute+Health%2C+LLC+Conducts+Voluntary+Nationwide+Recall+of+All+Lots+Of+Virilis+Pro%2C+PHUK+And+Prolifta+Capsules+Due+To+Undeclared+Ingredients - September 24, 2013 - Williamstown, New Jersey - Haute Health, LLC is voluntarily recalling all lots of Virilis Pro, PHUK and Prolifta at the retail and consumer level. Virilis Pro, PHUK and Prolifta have been found to contain amounts of the PDE-5 Inhibitor sildenafil, which is an active ingredient in an FDA-approved drug for erectile dysfunction (ED). This issue was brought to our attention as a result of sample-testing conducted by the FDA. ... Mon, 30 Sep 2013 07:00:00 +0100